Cambridge, UK : 12 - 14 September 2019
Nanotechnology offers exciting opportunities in the fight against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale.
As examples, the delivery of RNA with nanoparticles (in the product patisiran), has been approved by EMA/FDA in 2018, while the first liquid biopsy for prostate cancer based on exosome analysis was launched in 2016.
This conference aims to bridge nanotechnology with clinical and pre-clinical cancer research, and to highlight recent applications in patient care. It will provide an overview of the latest developments in the field of cancer-related nanotechnologies. There will be many opportunities to present work, with lively poster sessions and eight proffered papers selected from submitted abstracts.
Nanomedicine for effective delivery of siRNA, mRNA, CRISPR-Cas9, and others
Exosomes in cancer theranostics
Detection and combined treatments of early stage disease
Nanomedicine and cancer immunotherapy
Bursary application deadline:
01 July 2019
Abstract submission deadline:
01 July 2019
12 August 2019
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.